美国儿童脓毒症的细菌与真菌病原学:重新考虑经验性治疗
该回顾性队列研究利用2014年美国全国再入院数据库,纳入19,113例<19岁非新生儿脓毒症出院病例,其中33%既往健康、67%有慢性病,31%接受机械通气、19%有休克、3.1%住院期间死亡。42.9%的病例分离到细菌或真菌病原,金黄色葡萄球菌在既往健康者(9.4%)和任何慢性病者(11.1%)中均为最常见病原。耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌、艰难梭菌和真菌感染在特定慢性病人群中高发,这些慢性病与频繁医疗接触、早期手术、留置装置或免疫抑制相关。作者认为,临床医生在儿童脓毒症经验性抗菌治疗时应考虑覆盖这些病原。
要点
- 在19,113例儿童脓毒症住院中,42.9%分离到细菌或真菌病原,金黄色葡萄球菌是最常见病原。
- 既往健康患儿中金黄色葡萄球菌占9.4%(n=593),任何慢性病患儿中占11.1%(n=1,430)。
- 耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌、艰难梭菌和真菌感染在特定慢性病患儿中高发,这些慢性病与频繁医疗接触、早期手术、留置装置或免疫抑制相关。
- 作者认为,儿童脓毒症经验性抗菌治疗时应考虑覆盖上述病原。
适用人群与场景
- 出院时年龄小于19岁、非新生儿、出院诊断含脓毒症的患儿。
- 数据来源为2014年美国全国再入院数据库,覆盖美国非联邦医院近半数出院记录。
研究设计与关键结果
- 研究类型为回顾性队列研究,使用行政数据;样本为19,113例儿童脓毒症住院,其中既往健康6,300例(33%)、有慢性病12,813例(67%)。
- 31%接受机械通气,19%有休克,588例(3.1%)住院期间死亡。
- 8,204例(42.9%)分离到细菌或真菌病原。
- 金黄色葡萄球菌为最常见病原:既往健康者中593例(9.4%),任何慢性病者中1,430例(11.1%)。
- 耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌、艰难梭菌和真菌感染在特定慢性病患儿中高发,这些慢性病与频繁医疗接触、早期手术、留置装置或免疫抑制相关。
证据类型、等级与局限
- 证据类型为回顾性队列研究,使用全国代表性行政数据库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,临床医生在儿童脓毒症经验性抗菌治疗时应考虑覆盖耐甲氧西林金黄色葡萄球菌、真菌、铜绿假单胞菌和艰难梭菌。
- 上述考虑尤其针对存在与频繁医疗接触、早期手术、留置装置或免疫抑制相关的特定慢性病的患儿。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Timely empiric antimicrobial therapy is associated with improved outcomes in pediatric sepsis, but minimal data exist to guide empiric therapy. We sought to describe the prevalence of four pathogens that are not part of routine empiric coverage (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Clostridium difficile, and fungal infections) in pediatric sepsis patients in a contemporary nationally representative sample.
DESIGN: This was a retrospective cohort study using administrative data.
SETTING: We used the Nationwide Readmissions Database from 2014, which is a nationally representative dataset that contains data from nearly half of all discharges from nonfederal hospitals in the United States.
PATIENTS: Discharges of patients who were less than 19 years old at discharge and were not neonatal with a discharge diagnosis of sepsis.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of the 19,113 pediatric admissions with sepsis (6,300 [33%] previously healthy and 12,813 [67%] with a chronic disease), 31% received mechanical ventilation, 19% had shock, and 588 (3.1%) died during their hospitalization. Among all admissions, 8,204 (42.9%) had a bacterial or fungal pathogen identified. S. aureus was the most common pathogen identified in previously healthy patients (n = 593, 9.4%) and those with any chronic disease (n = 1,430, 11.1%). Methicillin-resistant S. aureus, P. aeruginosa, C. difficile, and fungal infections all had high prevalence in specific chronic diseases associated with frequent contact with the healthcare system, early surgery, indwelling devices, or immunosuppression.
CONCLUSIONS: In this nationally representative administrative database, the most common identified pathogen was S. aureus in previously healthy and chronically ill children. In addition, a high proportion of children with sepsis and select chronic diseases had infections with methicillin-resistant S. aureus, fungal infections, Pseudomonas infections, and C. difficile. Clinicians caring for pediatric patients should consider coverage of these organisms when administering empiric antimicrobials for sepsis.
参考来源
- Prout AJ, Talisa VB, Carcillo JA, et al. Bacterial and Fungal Etiology of Sepsis in Children in the United States: Reconsidering Empiric Therapy. Crit Care Med. 2020. PMID: 31789702. doi:10.1097/CCM.0000000000004140
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。